Dapagliflozin trials for Type 2 diabetes

All Dapagliflozin trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Dapagliflozin for Type 2 diabetes

• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
  NCT07662044 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 149 locations
• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
  NCT07662109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 272 locations
• Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
  NCT02969798 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
  NCT05345327 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations

Common questions

How many trials study Dapagliflozin for Type 2 diabetes?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.